Author Interviews, COVID -19 Coronavirus, JAMA / 22.10.2021

MedicalResearch.com Interview with: Destin Groff, BA Ashley Sun BA Department of Surgery and Paddy Ssentongo MD PhD Department of Public Health Sciences Center for Neural Engineering Department of Engineering, Science and Mechanics The Pennsylvania State University, State College Penn State College of Medicine and Milton S. Hershey Medical Center Hershey, Pennsylvania  MedicalResearch.com: What is the background for this study? Response: Most people who get sick from COVID-19 will survive. However, the burden of long-term consequences among the survivors is not well-characterized. That is what inspired this study.  MedicalResearch.com: What are the main findings? Response: After compiling data from 57 studies involving 250,351 unvaccinated individuals, our study shows that more than half of those worldwide who have been diagnosed with COVID-19 experience six months after recovering. The most common sequelae involve functional mobility impairments, pulmonary abnormalities, and mental health disorders, including memory deficits, concentration difficulty, post-traumatic stress disorders, depression, and anxiety. (more…)
Author Interviews, JAMA, Mental Health Research / 23.07.2021

This story explores suicide and conditions leading to despair. If you are at risk, please stop here and contact the National Suicide Prevention Lifeline for support. 800-273-8255 MedicalResearch.com Interview with: Daniel George, MSc, PhD Associate Professor, Department of Humanities Associate Professor, Department of Public Health Sciences Penn State MedicalResearch.com: What is the background for this study? What are the common diseases of despair?  Response: Last decade, two Princeton economists, Anne Case and Angus Deaton, noted a precipitous rise in self-harming deaths (suicide, alcoholism, accidental poisonings, i.e., overdose) especially among poor whites in midlife with low educational attainment since the 1990s. These deaths were intimately linked with economic changes over the past several decades that have created more despairing conditions for the working class, made people more susceptible to seeking escape, numbness, and relief from physical, mental, and emotional pain. In recent years, the crisis has broadened, and we've seen rising excess mortality in other groups of working-class Americans as overall life expectancy has consistently fallen. Our team at Penn State College of Medicine and Highmark Inc. has previously examined “diseases of despair”, these being patients who are experiencing suicidal ideation or substance use issues and seeking out clinical care before they convert to "deaths of despair". We published a study in BMJ in 2020 showing a marked rise in these clinical diseases of despair across a sample of 12 million insurance carriers in Appalachia and the Rust Belt, again spanning across demographic boundaries. For this study, we honed in on high prevalence census blocks we had identified in our hospital's service area in central Pennsylvania and organized 4 focus groups in both rural and urban areas. We wanted to learn more about what people felt was driving despair in their communities, and what solutions might look like  (more…)
Author Interviews, COVID -19 Coronavirus, Dental Research / 21.10.2020

MedicalResearch.com Interview with: Craig Meyers, PhD Department of Microbiology and Immunology Pennsylvania State College of Medicine Hershey, PA MedicalResearch.com: What is the background for this study? Response: As nasal and oral cavities are major points of entry and transmission for human coronaviruses our team of physicians and scientists (Craig Meyers, Janice Milici, Samina Alam, David Quillen, David Goldenberg and Rena Kass of Penn State College of Medicine and Richard Robison of Brigham Young University) were interested in testing common over-the-counter oral antiseptics and mouthwashes for their efficacy to inactivate infectious human coronavirus, which is structurally similar to SARS-CoV-2, the virus that causes COVID-19. While we wait for a vaccine for COVID-19 to be developed, methods to reduce transmission are needed. We chose products that are readily available and often already part of people’s daily routines. (more…)